Document is current
Any future updates will be listed below
-
Authors
Gong, Katherine
Timsina, Jigyasha
Ali, Muhammad
Chen, Yike
Liu, Menghan
Wang, Ciyang
Pottier, Cyril
Feld, Geoffrey K.
Heo, Gyujin
S. Benzinger, Tammie L.
Raji, Cyrus A.
Ances, Beau
Gordon, Brian A.
Wisch, Julie K.
Schindler, Suzanne E.
Morris, John C.
Holtzman, David M.
Ibanez, Laura
Cruchaga, Carlos
- License Information
-
More Information
Article History
Received: 13 April 2025
Accepted: 13 October 2025
First Online: 17 November 2025
Declaration
:
: CC is a member of the scientific advisory board of Circular Genomics and owns stocks and is on the scientific advisory board of ADmit and Alamar. CC consults for Sanofi, NovoNordisk, and Owkin. CC has received research support from GSK, Danaher and EISAI. GF receives consulting fees from Alamar Biosciences. D.M.H. co-founded, has equity, receives royalty income, and is on the scientific advisory board of C2N Diagnostics. He is on the scientific advisory boards of Denali, Genentech, Cajal Neuroscience, and Switch Therapeutics and consults for Roche and Pfizer.
